CN Stock MarketDetailed Quotes
301108 Tongling Jieya Biologic Technology
- 30.40
- +0.70+2.36%
Market Closed Dec 13 15:00 CST
2.47BMarket Cap43.87P/E (TTM)
30.98High29.40Low19.46KlotVolume29.70Open29.70Pre Close59.17MTurnover5.52%Turnover Ratio21.42P/E (Static)81.21MShares35.2252wk High1.33P/B1.07BFloat Cap20.8152wk Low35.64Limit Up35.24MShs Float95.97Historical High23.76Limit Down5.32%Amplitude20.81Historical Low0.36Dividend TTM30.40Avg Price8.88KlotAsk1.18%Div YieldTTM100Lot Size9.86KlotBid
Tongling Jieya Biologic Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -8.79%407.97M | 1.99%285.07M | 1.43%129.64M | -6.60%622.59M | -14.91%447.27M | -22.26%279.52M | -29.24%127.8M | -32.29%666.56M | -35.46%525.64M | -42.62%359.55M |
| Operating revenue | -8.79%407.97M | 1.99%285.07M | 1.43%129.64M | -6.60%622.59M | -14.91%447.27M | -22.26%279.52M | -29.24%127.8M | -32.29%666.56M | -35.46%525.64M | -42.62%359.55M |
| Other operating revenue | ---- | -80.55%3.57M | ---- | 65.43%30.2M | ---- | 18.54%18.36M | ---- | 28.38%18.25M | ---- | 156.21%15.49M |
| Total operating cost | 6.06%385.58M | 20.49%264.89M | 32.12%124.19M | 0.21%513.52M | -2.48%363.56M | -13.78%219.84M | -27.22%93.99M | -30.88%512.42M | -38.52%372.81M | -45.74%254.98M |
| Operating cost | 7.38%328.67M | 22.01%228.34M | 31.10%104.56M | -4.09%438.15M | -12.80%306.09M | -22.87%187.16M | -33.97%79.75M | -30.91%456.83M | -35.86%351.03M | -42.67%242.66M |
| Operating tax surcharges | -25.23%3.02M | -6.24%2.35M | 13.67%1.28M | 35.21%6.57M | 20.64%4.04M | 79.79%2.51M | 94.22%1.12M | -31.86%4.86M | -45.90%3.35M | -70.06%1.39M |
| Operating expense | -8.78%7.58M | 33.96%4.98M | 69.06%2.55M | 34.86%9.66M | 107.14%8.31M | 60.06%3.71M | 66.71%1.51M | 2.99%7.16M | -26.59%4.01M | -35.42%2.32M |
| Administration expense | 3.01%37.78M | 14.33%25.53M | 10.82%12.14M | 38.08%48.56M | 59.24%36.67M | 72.27%22.33M | 74.95%10.96M | 30.31%35.17M | 36.51%23.03M | 8.10%12.96M |
| Financial expense | 32.12%-6.35M | 12.03%-6.28M | 63.53%-1.62M | 29.28%-11.94M | 66.22%-9.36M | 59.76%-7.14M | 18.35%-4.44M | -730.32%-16.89M | -2,489.31%-27.71M | -744.88%-17.75M |
| -Interest expense (Financial expense) | -17.02%536.3K | -88.71%411.26K | -22.31%207.75K | -45.80%1.01M | -54.21%646.28K | 283.54%3.64M | -44.19%267.39K | 14.89%1.86M | 24.35%1.41M | 20.95%949.64K |
| -Interest Income (Financial expense) | 17.44%-6.67M | 37.24%-5.7M | 26.92%-2.31M | 6.45%-11.86M | 53.92%-8.08M | 21.78%-9.08M | 43.07%-3.16M | -109.50%-12.68M | -361.78%-17.53M | -382.86%-11.61M |
| Research and development | -16.44%14.88M | -11.57%9.97M | 3.64%5.28M | -10.96%22.52M | -6.72%17.81M | -15.83%11.27M | -15.81%5.09M | -30.48%25.29M | -35.10%19.09M | -43.43%13.39M |
| Credit Impairment Loss | -27.36%690.79K | -12.75%467.03K | -41.70%1.64M | 239.33%1.14M | 158.17%951.02K | 127.40%535.28K | 382.24%2.82M | -17.42%-814.6K | -706.91%-1.63M | -15.07%-1.95M |
| Asset Impairment Loss | -233.20%-1.73M | -283.98%-1.38M | 290.86%195.17K | -158.37%-11.98M | 92.73%-517.79K | 89.55%-359.54K | 88.35%-102.26K | -155.34%-4.64M | -202.69%-7.12M | -67.76%-3.44M |
| Other net revenue | -26.06%16.5M | -34.73%9.52M | 1.35%9.13M | 46.56%25.78M | 855.56%22.31M | 2,571.46%14.59M | 167.51%9.01M | 161.45%17.59M | -187.00%-2.95M | -140.90%-590.18K |
| Fair value change income | 53.76%7.22M | 111.05%4.2M | 970.18%2.5M | 795.57%9.06M | 213.11%4.7M | 188.68%1.99M | -82.90%233.27K | -15.57%1.01M | ---4.15M | ---2.24M |
| Invest income | -42.79%7.19M | -53.55%4.38M | -15.59%3.8M | 55.44%18.52M | 563.12%12.57M | 1,276.78%9.43M | --4.5M | --11.92M | --1.9M | --685K |
| -Including: Investment income associates | ---7.98M | ---5.49M | ---927.09K | ---810.05K | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | 70.45%-29.85K | -77.37%-29.85K | -52.71%6.09K | -72.18%319.55K | -312.96%-101.01K | -124.44%-16.83K | --12.88K | 295.26%1.15M | -83.68%47.43K | -70.51%68.84K |
| Other revenue | -33.21%3.15M | -37.30%1.89M | -35.86%994.39K | -2.74%8.72M | -41.15%4.72M | -52.19%3.01M | -32.53%1.55M | 15.69%8.96M | 54.50%8.01M | 92.43%6.29M |
| Operating profit | -63.32%38.89M | -60.00%29.71M | -65.94%14.58M | -21.48%134.85M | -29.26%106.02M | -28.58%74.26M | -21.91%42.82M | -31.27%171.73M | -29.13%149.88M | -33.51%103.98M |
| Add:Non operating Income | 246.56%1.36M | 674.90%1.36M | 13,888.41%1.17M | -43.16%417.93K | -37.51%391.83K | -71.30%175.08K | -95.83%8.38K | -70.81%735.25K | -38.21%627K | 2.68%610K |
| Less:Non operating expense | 234.06%731.6K | 528.04%673.78K | 66,115.10%616.75K | -97.48%259.95K | -90.45%219K | -95.09%107.28K | -99.83%931.44 | 1,931.73%10.3M | 566.13%2.29M | 2,630.77%2.18M |
| Total profit | -62.79%39.51M | -59.12%30.39M | -64.65%15.14M | -16.75%135.01M | -28.35%106.2M | -27.41%74.33M | -21.38%42.83M | -35.61%162.16M | -30.14%148.22M | -34.73%102.4M |
| Less:Income tax cost | -62.65%4.94M | -58.33%3.89M | -77.22%1.27M | -3.46%20.46M | -31.37%13.24M | -29.49%9.34M | -20.83%5.56M | -33.35%21.2M | -28.60%19.29M | -32.79%13.25M |
| Net profit | -62.81%34.57M | -59.23%26.5M | -62.77%13.87M | -18.75%114.54M | -27.90%92.96M | -27.10%64.99M | -21.47%37.26M | -35.94%140.97M | -30.37%128.93M | -35.01%89.16M |
| Net profit from continuing operation | -62.81%34.57M | -59.23%26.5M | -62.77%13.87M | -18.75%114.54M | -27.90%92.96M | -27.10%64.99M | -21.47%37.26M | -35.94%140.97M | -30.37%128.93M | -35.01%89.16M |
| Less:Minority Profit | 81.26%-115.1K | 16.71%-91.06K | -280.73%-29.33K | ---655.9K | ---614.36K | ---109.33K | ---7.7K | ---- | ---- | ---- |
| Net profit of parent company owners | -62.94%34.68M | -59.16%26.59M | -62.70%13.9M | -18.28%115.2M | -27.42%93.58M | -26.98%65.1M | -21.45%37.27M | -35.94%140.97M | -30.37%128.93M | -35.01%89.16M |
| Earning per share | ||||||||||
| Basic earning per share | -62.61%0.43 | -58.75%0.33 | -63.04%0.17 | -18.39%1.42 | -27.67%1.15 | -27.27%0.8 | -20.69%0.46 | -50.57%1.74 | -47.70%1.59 | -51.11%1.1 |
| Diluted earning per share | -62.61%0.43 | -58.75%0.33 | -63.04%0.17 | -18.39%1.42 | -27.67%1.15 | -27.27%0.8 | -20.69%0.46 | -50.57%1.74 | -47.70%1.59 | -51.11%1.1 |
| Other composite income | ||||||||||
| Total composite income | -62.81%34.57M | -59.23%26.5M | -62.77%13.87M | -18.75%114.54M | -27.90%92.96M | -27.10%64.99M | -21.47%37.26M | -35.94%140.97M | -30.37%128.93M | -35.01%89.16M |
| Total composite income of parent company owners | -62.94%34.68M | -59.16%26.59M | -62.70%13.9M | -18.28%115.2M | -27.42%93.58M | -26.98%65.1M | -21.45%37.27M | -35.94%140.97M | -30.37%128.93M | -35.01%89.16M |
| Total composite income of minority owners | 81.26%-115.1K | 16.71%-91.06K | -280.73%-29.33K | ---655.9K | ---614.36K | ---109.33K | ---7.7K | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
